Workflow
恒星科技(002132) - 2019 Q3 - 季度财报

Financial Performance - Operating revenue for the reporting period was CNY 882,938,870.72, an increase of 6.07% year-on-year [7]. - Net profit attributable to shareholders was CNY 58,497,819.85, a significant increase of 168.55% compared to the same period last year [7]. - Basic earnings per share reached CNY 0.0478, reflecting a growth of 176.30% year-on-year [7]. - Total operating revenue for Q3 2019 was CNY 882,938,870.72, an increase of 6.4% compared to CNY 832,446,255.04 in the same period last year [37]. - Net profit attributable to the parent company for Q3 2019 was CNY 204,160,942.87, compared to CNY 175,641,779.71 in the previous year, representing a growth of 16.2% [34]. - The total profit for the third quarter was CNY 66,685,576.61, compared to a loss of CNY 7,994,154.76 in the previous year [40]. - The company's operating profit for the third quarter was CNY 62,330,756.61, a turnaround from a loss of CNY 9,603,760.82 in the same period last year [40]. - The total comprehensive income for the third quarter was CNY 58,497,819.85, compared to CNY 10,691,002.95 in the previous year [39]. Cash Flow - The net cash flow from operating activities was negative at CNY -56,264,622.18, a decrease of 35.51% compared to the previous year [7]. - The company reported a net cash flow from operating activities of ¥223,881,192.95, a significant increase of 305.00% compared to a negative cash flow of ¥109,210,038.34 in the previous period [26]. - The net cash flow from operating activities was CNY 223,881,192.95, compared to a negative cash flow of CNY 109,210,038.34 in the previous period [52]. - The total cash inflow from investment activities is CNY 1,182,309,311.66, significantly higher than CNY 391,128,107.70 in the previous period [55]. - The net cash flow from investment activities is CNY 85,285,478.26, recovering from a negative CNY 132,611,298.57 in the previous period [55]. - The total cash inflow from financing activities is CNY 1,470,823,470.83, up from CNY 737,780,346.48 in the previous period [56]. - The net cash flow from financing activities is -CNY 215,472,892.39, a decline from CNY 25,663,113.77 in the previous period [56]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 5,309,836,773.51, a decrease of 3.26% compared to the end of the previous year [7]. - The total assets decreased to ¥5,309,836,773.51 from ¥5,488,550,361.39, reflecting a decline of approximately 3.25% [28]. - The company's total liabilities decreased to ¥3,155,647,188.49 from ¥3,227,348,680.00, indicating a reduction of approximately 2.22% [28]. - Total liabilities decreased to CNY 1,693,626,689.82 from CNY 1,914,627,760.03, indicating a reduction of 11.5% [34]. - The company's total equity as of September 30, 2019, was CNY 2,473,444,360.67, down from CNY 2,559,701,103.02, a decline of 3.4% [35]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 47,530 [10]. - The largest shareholder, Xie Baojun, holds 21.16% of the shares, amounting to 265,927,345 shares [10]. - The company did not engage in any repurchase transactions during the reporting period [11]. - The company repurchased a total of 39,561,797 shares, representing 3.15% of the total share capital, with a total transaction amount of ¥117,922,595.09 [17]. Other Income and Expenses - The company reported non-recurring gains and losses totaling CNY 66,975,288.95 for the year-to-date [8]. - The investment income decreased by 47.63% to ¥6,775,734.45 from ¥12,937,942.63, primarily due to reduced financial product returns [26]. - The company experienced a 113.04% increase in non-operating income to ¥10,832,288.98 from ¥5,084,582.80, primarily due to increased government subsidies received [26]. - The company reported a significant increase in other income by 151.43% to ¥37,080,389.23 from ¥14,748,038.35, mainly due to increased tax refunds for welfare enterprises [26]. - Research and development expenses for the third quarter were CNY 9,926,155.56, slightly up from CNY 9,320,902.92 in the previous year [40]. - Research and development expenses increased to CNY 30,268,100.51 from CNY 26,053,550.55, reflecting a growth of approximately 8.5% [48]. Audit and Adjustments - The third-quarter report has not been audited [57]. - The company has not made any adjustments to financial statements due to the new financial instrument standards or new leasing standards [57].